glycine has been researched along with Muscular Dystrophy, Duchenne in 5 studies
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The L-arginine/nitric oxide synthase (NOS) pathway is considered to be altered in muscular dystrophy such as Becker muscular dystrophy (BMD)." | 9.27 | Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications. ( Bollenbach, A; Bonati, U; Fischer, D; Hafner, P; Hanff, E; Kayacelebi, AA; Tsikas, D, 2018) |
| "The L-arginine/nitric oxide synthase (NOS) pathway is considered to be altered in muscular dystrophy such as Becker muscular dystrophy (BMD)." | 5.27 | Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications. ( Bollenbach, A; Bonati, U; Fischer, D; Hafner, P; Hanff, E; Kayacelebi, AA; Tsikas, D, 2018) |
| "Treatment with ixazomib had no toxic effect on the mdx mouse." | 1.62 | Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice. ( Bertassoli, BM; Carvalho, AAS; Feder, D; Fonseca, FLA; Hermes, TA; Micheletto, MLJ; Perez, MM; Petri, G, 2021) |
| "Glycine treatment attenuated fibrotic deposition in the diaphragm by 28% (P < 0." | 1.51 | Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice. ( Alves, FM; Caldow, MK; Chee, A; Gardner, A; Ham, DJ; Kennedy, TL; Koopman, R; Lynch, GS; Naim, T; Trieu, J, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, G | 4 |
| Lin, C | 4 |
| Yin, H | 4 |
| Ham, DJ | 1 |
| Gardner, A | 1 |
| Kennedy, TL | 1 |
| Trieu, J | 1 |
| Naim, T | 1 |
| Chee, A | 1 |
| Alves, FM | 1 |
| Caldow, MK | 1 |
| Lynch, GS | 1 |
| Koopman, R | 1 |
| Ning, H | 1 |
| Song, J | 1 |
| Ran, N | 1 |
| Yi, X | 1 |
| Seow, Y | 1 |
| Micheletto, MLJ | 1 |
| Hermes, TA | 1 |
| Bertassoli, BM | 1 |
| Petri, G | 1 |
| Perez, MM | 1 |
| Fonseca, FLA | 1 |
| Carvalho, AAS | 1 |
| Feder, D | 1 |
| Hanff, E | 1 |
| Hafner, P | 1 |
| Bollenbach, A | 1 |
| Bonati, U | 1 |
| Kayacelebi, AA | 1 |
| Fischer, D | 1 |
| Tsikas, D | 1 |
1 trial available for glycine and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications.
Topics: Adult; Amidinotransferases; Arginine; Citrulline; Creatinine; Dietary Supplements; Female; Glycine; | 2018 |
4 other studies available for glycine and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Use of Glycine to Augment Exon Skipping and Cell Therapies for Duchenne Muscular Dystrophy.
Topics: Animals; Dystrophin; Exons; Fabaceae; Glycine; Mice; Muscular Dystrophy, Duchenne; Oligonucleotides, | 2023 |
Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Glycine; Glycine Agents; Male; Mice; Mice | 2019 |
Glycine Enhances Satellite Cell Proliferation, Cell Transplantation, and Oligonucleotide Efficacy in Dystrophic Muscle.
Topics: Animals; Cell Proliferation; Cell Transplantation; Disease Models, Animal; Drug Synergism; Glycine; | 2020 |
Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice.
Topics: Animals; Boron Compounds; Dystrophin; Glycine; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystroph | 2021 |